Severity of infection from Omicron—reviewing the data [5:15];

Factors contributing to the relative mildness of Omicron infections [8:30];

Is SARS-CoV-2 evolving to cause less severe disease? [13:00];

Potential of Covaxin—an inactivated virus-based COVID-19 vaccine [17:45];

How B cells and T cells work together to defend against viruses [22:00];

Comparing the COVID-19 vaccines, and the rationale for the time between doses [25:30];

Reviewing the purpose and effectiveness of boosters for reducing severity and transmission [32:30];

Debating vaccine mandates, and putting COVID’s mortality risk in perspective [41:00];

Why the topic of COVID has become so polarized [1:03:15];

Reviewing the data on masks for protecting oneself and protecting others [1:06:30];

The inconsistent logic used for mask mandates [1:16:00];

Long COVID and the potential for vaccines to reduce risk [1:21:45];

Risks for children and policies for schools [1:27:30];

Reviewing the outcomes from Sweden, where the government didn’t impose lockdowns [1:31:00];

Draconian measures implemented in Canada [1:28:15];

Antiviral treatments for COVID and a common-sense approach [1:42:15];

Importance of ending tribalism and having rational discussions with humility [1:47:30];

Treating infection with monoclonal antibodies and convalescent sera [2:01:45];

Reviewing claims made by the controversial Dr. Robert Malone [2:11:15];

A potential exit strategy from the current situation [2:30:30];

Change needed at the NIH [2:40:00]